ArticleCureus2025
A Novel Scoring System for Pilonidal Disease: Predicting Complications and Guiding Surgical Management.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPilonidal disease is a chronic condition of the sacrococcygeal region, frequently affecting young adults and associated with high rates of recurrence and postoperative complications. Numerous surgical techniques have been described, yet there is no universally accepted classification or staging system to guide treatment decisions. This lack of standardization contributes to inconsistent outcomes and difficulty in predicting prognosis.
objectiveThis study aimed to develop and validate a novel preoperative scoring system, the Hazem-Talaat score, to assess disease severity, predict recurrence, and facilitate surgical planning in pilonidal disease.
methodsA prospective study was carried out on 156 patients (108 males, 48 females) aged 18-45 years admitted with primary or recurrent pilonidal disease to the General Surgery Department at Tanta University, Egypt, between June 2023 and June 2024. Patients with recurrent disease after flap repair or with hematological disorders were excluded, as the reason for this is to avoid anatomical distortions caused by flap surgeries. Preoperative variables, including BMI, sex, hair distribution, diabetes mellitus, number and location of pits, distance from the anus, history of abscess, and prior recurrence, were incorporated into the Hazem-Talaat score. All patients underwent standardized asymmetrical elliptical excision with off-midline closure and were followed for at least six months to assess wound complications and recurrence.
resultsThe mean age of participants was 27.3 ± 6.5 years, and the mean BMI was 29.1 ± 4.6 kg/m². Recurrence occurred in 19 patients (12.2%), while wound dehiscence was noted in 26 patients (16.7%). Recurrence was significantly associated with male gender (p = 0.010), higher BMI (p < 0.001), diabetes mellitus (p < 0.001), prolonged operative time (p < 0.001), prior recurrence (p < 0.001), more than 10 midline pits (p < 0.001), lateral extension (p < 0.001), hairy back (p < 0.001), distance from anus < 5 cm (p < 0.001), and previous abscess formation (p < 0.001). Patients who developed recurrence had significantly higher Hazem-Talaat scores (mean 22.1 ± 4.5) compared with those without recurrence (mean 14.0 ± 3.1; p < 0.001). A cut-off value of 21 was determined using a receiver operating characteristic (ROC) curve.
conclusionThe Hazem-Talaat score provides an objective, multifactorial tool that integrates clinical and anatomical factors to predict recurrence and stratify patients with pilonidal disease. Its application in surgical planning may improve outcomes by tailoring the choice of operative technique to disease severity. Further multicenter studies with longer follow-up are warranted to externally validate this system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.